To test this hypothesis, we evaluated whether SK1 proteolysis is downstream of caspase‐2 activation using a variety of methods in WT p53 human breast cancer cells and also whether caspase‐2 is required for SK1 proteolysis using both biochemical and genetic models. The gene discussed is SPHK1; the disease is breast carcinoma.